Research

Globally coronary heart diseases (caused by narrowed arteries that supply the heart with blood) claim nearly nine million lives each year1, the largest of any disease, and present a huge burden to health systems.

Writing in the journal Nature Immunology, they detail an investigation into one of the key features of adenovirus vaccines – their ability to generate strong and sustained populations of the ‘killer’ T-cell element of the i

A new study by researchers at the University of Oxford, Queen Mary University of London, Institute for Advanced Studies, Vienna, and the Medical University of Graz, has found that lateral flow tests detect Covid-19 with similar accuracy to laboratory-based PCR tests, providing they are used at th

High levels of glucose in the blood ‘reprogrammes’ stem cells, leading to a lasting increase in the risk of developing dangerous atherosclerosis, according to research funded by the British Heart Foundation published today in Circulation.

Dr Arlene Holmes-Henderson is engaging with policy makers to share her research findings, which include that studying Classics can help students develop vital skills for education, life, and work in the 21st Century.

A new social enterprise is offering low-cost, easily accessible testing to diagnose blood and other diseases in sub-Saharan Africa.

A new vaccine, developed and evaluated in conjunction with Oxford scientists, has proved effective against typhoid, and is influencing global policy on vaccination.

The Oxford University research project Europe’s Stories, led by Professor Timothy Garton Ash, aims to explore what Europeans really think about Europe, what people’s real experiences of Europe are, and what they want the EU to do by 2030.

Oxford’s Environmental Change Institute has developed new modelling tools to help decision makers identify risks from climate-related infrastructure failure and build long-term resilience.

Cutting-edge gene therapies for eye diseases can help improve quality of life, extend the working lives of patients, and reduce treatment costs.

A global network, coordinated by Oxford University, is helping to ensure health research benefits low-income countries.

Researchers at the Department of Chemistry are developing technologies to make recycling plastics easy, clean and affordable – promoting a truly ‘circular economy’ for the material.

The Medical Sciences Division’s Business Partnerships Office is celebrating ten years of developing productive relationships and supporting effective collaborations with industry.

Researchers from the University of Oxford and their partners have today reported findings from a Phase IIb trial of a candidate malaria vaccine, R21/Matrix-M, which demonstrated high-level efficacy of 77% over 12-months of follow-up.

Our vaccine work is progressing quickly.

Our vaccine work is progressing quickly.

The Phase I trial, which will enrol 30 healthy volunteers aged 18–40, will investigate the level of immune system responses generated by the vaccine using this delivery technique, as well as monitoring safety and for any adverse reactions.

The Arctic Bears Project is being led by Professor Douglas Clark, of the University of Saskatchewan, in collaboration with penguinologist Dr Tom Hart of Oxford’s Department of Zoology.

Our vaccine work is progressing quickly.

Azithromycin and doxycycline are two commonly used antibiotics investigated as separate treatments in the trial. Both drugs are being used by some doctors in the hope of treating COVID-19 in the early stages of the illness.